We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
67 hedge funds and large institutions have $142M invested in CTI BioPharma Corp. (DE) Common Stock in 2018 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 21 increasing their positions, 4 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
652% more call options, than puts
Call options by funds: $451K | Put options by funds: $60K
425% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 4
168% more capital invested
Capital invested by funds: $52.7M → $142M (+$88.8M)
140% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 10
26% more funds holding
Funds holding: 53 → 67 (+14)
Holders
67
Holders Change
+14
Holders Change %
+26.42%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
21
Reduced
4
Closed
10
Calls
$451K
Puts
$60K
Net Calls
+$391K
Net Calls Change
+$286K
Top Buyers
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$5.86M |
| 2 |
Jane Street
New York
|
-$472K |
| 3 |
TA
Tiedemann Advisors
New York
|
-$196K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$176K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$170K |
